Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/2292
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorDANTAS, Wagner Silva-
dc.contributor.authorGUALANO, Bruno-
dc.contributor.authorROCHA, Michele Patrocinio-
dc.contributor.authorBARCELLOS, Cristiano Roberto Grimaldi-
dc.contributor.authorYANCE, Viviane dos Reis Vieira-
dc.contributor.authorMARCONDES, Jose Antonio Miguel-
dc.date.accessioned2013-09-23T16:50:39Z-
dc.date.available2013-09-23T16:50:39Z-
dc.date.issued2013-
dc.identifier.citationSCIENTIFIC WORLD JOURNAL, article ID 178364, 7p, 2013-
dc.identifier.issn1537-744X-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/2292-
dc.description.abstractPolycystic ovary syndrome is a complex hormonal disorder affecting the reproductive and metabolic systems with signs and symptoms related to anovulation, infertility, menstrual irregularity and hirsutism. Skeletal muscle plays a vital role in the peripheral glucose uptake. Since PCOS is associated with defects in the activation and pancreatic dysfunction of beta-cell insulin, it is important to understand the molecular mechanisms of insulin resistance in PCOS. Studies of muscle tissue in patients with PCOS reveal defects in insulin signaling. Muscle biopsies performed during euglycemic hyperinsulinemic clamp showed a significant reduction in glucose uptake, and insulin-mediated IRS-2 increased significantly in skeletal muscle. It is recognized that the etiology of insulin resistance in PCOS is likely to be as complicated as in type 2 diabetes and it has an important role in metabolic and reproductive phenotypes of this syndrome. Thus, further evidence regarding the effect of nonpharmacological approaches (e.g., physical exercise) in skeletal muscle of women with PCOS is required for a better therapeutic approach in the management of various metabolic and reproductive problems caused by this syndrome.-
dc.description.sponsorshipFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/02827-7, 2012/14650-4]-
dc.language.isoeng-
dc.publisherHINDAWI PUBLISHING CORPORATION-
dc.relation.ispartofScientific World Journal-
dc.rightsopenAccess-
dc.subject.otherpolycystic-ovary-syndrome-
dc.subject.otherimpaired glucose-tolerance-
dc.subject.otherinsulin-resistance-
dc.subject.otherpioglitazone treatment-
dc.subject.otherandrogen excess-
dc.subject.otheradipose-tissue-
dc.subject.otherwomen-
dc.subject.otherprevalence-
dc.subject.othertransport-
dc.subject.otherhealth-
dc.titleMetabolic Disturbance in PCOS: Clinical and Molecular Effects on Skeletal Muscle Tissue-
dc.typearticle-
dc.rights.holderCopyright HINDAWI PUBLISHING CORPORATION-
dc.identifier.doi10.1155/2013/178364-
dc.identifier.pmid23844380-
dc.subject.wosMultidisciplinary Sciences-
dc.type.categoryreview-
dc.type.versionpublishedVersion-
hcfmusp.author.externalDANTAS, Wagner Silva:Univ Sao Paulo, Sch Phys Educ & Sport, Lab Appl Nutr & Metab, BR-05508030 Sao Paulo, Brazil-
hcfmusp.author.externalGUALANO, Bruno:Univ Sao Paulo, Sch Phys Educ & Sport, Lab Appl Nutr & Metab, BR-05508030 Sao Paulo, Brazil-
hcfmusp.author.externalROCHA, Michele Patrocinio:Univ Sao Paulo, Div Endocrinol, Sch Med, BR-05508030 Sao Paulo, Brazil-
hcfmusp.author.externalBARCELLOS, Cristiano Roberto Grimaldi:Univ Sao Paulo, Div Endocrinol, Sch Med, BR-05508030 Sao Paulo, Brazil-
hcfmusp.description.articlenumber178364-
hcfmusp.description.volume2013-
hcfmusp.origemWOS-
hcfmusp.origem.id2-s2.0-84879330751-
hcfmusp.origem.idWOS:000320522800001-
hcfmusp.publisher.cityNEW YORK-
hcfmusp.publisher.countryUSA-
hcfmusp.relation.referenceAbdul-Ghani MA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/476279-
hcfmusp.relation.referenceApridonidze T, 2005, J CLIN ENDOCR METAB, V90, P1929, DOI 10.1210/jc.2004-1045-
hcfmusp.relation.referenceAzziz R, 2006, J CLIN ENDOCR METAB, V91, P4237, DOI 10.1210/jc.2006-0178-
hcfmusp.relation.referenceAzziz R, 2009, FERTIL STERIL, V91, P456, DOI 10.1016/j.fertnstert.2008.06.035-
hcfmusp.relation.referenceBandyopadhyay GK, 2006, DIABETES, V55, P2277, DOI 10.2337/db06-0062-
hcfmusp.relation.referenceBarcellos CRG, 2007, ARQ BRAS ENDOCRINOL, V51, P601, DOI 10.1590/S0004-27302007000400015-
hcfmusp.relation.referenceBargiota Alexandra, 2012, Ther Adv Endocrinol Metab, V3, P27, DOI 10.1177/2042018812437355-
hcfmusp.relation.referenceBlaak EE, 2005, BEST PRACT RES CL EN, V19, P391, DOI 10.1016/j.beem.2005.04.001-
hcfmusp.relation.referenceBrettenthaler N, 2004, J CLIN ENDOCR METAB, V89, P3835, DOI 10.1210/jc.2003-031737-
hcfmusp.relation.referenceCiampelli M, 2005, J CLIN ENDOCR METAB, V90, P1398, DOI 10.1210/jc.2004-0410-
hcfmusp.relation.referenceCiaraldi TP, 2009, J CLIN ENDOCR METAB, V94, P157, DOI 10.1210/jc.2008-1492-
hcfmusp.relation.referenceCline GW, 1999, NEW ENGL J MED, V341, P240, DOI 10.1056/NEJM199907223410404-
hcfmusp.relation.referenceCorbould A, 2008, PANMINERVA MED, V50, P279-
hcfmusp.relation.referenceCorbould A, 2005, AM J PHYSIOL-ENDOC M, V288, pE1047, DOI 10.1152/ajpendo.00361.2004-
hcfmusp.relation.referenceDeFronzo RA, 1997, DIABETES REV, V5, P177-
hcfmusp.relation.referencede Paula Martins W, 2007, EUR J OBSTET GYN R B, V133, P203, DOI 10.1016/j.ejogrb.2006.10.038-
hcfmusp.relation.referenceDiamanti-Kandarakis E, 2006, TRENDS MOL MED, V12, P324, DOI 10.1016/j.molmed.2006.05.006-
hcfmusp.relation.referenceDiamanti-Kandarakis E, 2012, ENDOCR REV, V33, P981, DOI 10.1210/er.2011-1034-
hcfmusp.relation.referenceDOUEN AG, 1990, J BIOL CHEM, V265, P13427-
hcfmusp.relation.referenceDUNAIF A, 1995, J CLIN INVEST, V96, P801, DOI 10.1172/JCI118126-
hcfmusp.relation.referenceDunaif A, 1997, ENDOCR REV, V18, P774, DOI 10.1210/er.18.6.774-
hcfmusp.relation.referenceDunaif A, 2001, AM J PHYSIOL-ENDOC M, V281, pE392-
hcfmusp.relation.referenceDUNAIF A, 1989, DIABETES, V38, P1165, DOI 10.2337/diabetes.38.9.1165-
hcfmusp.relation.referenceEhrmann DA, 1999, DIABETES CARE, V22, P141, DOI 10.2337/diacare.22.1.141-
hcfmusp.relation.referenceFauser BCJM, 2012, FERTIL STERIL, V97, P28, DOI 10.1016/j.fertnstert.2011.09.024-
hcfmusp.relation.referenceFulghesu AM, 2006, FERTIL STERIL, V86, P398, DOI 10.1016/j.fertnstert.2006.01.024-
hcfmusp.relation.referenceGeloneze Bruno, 2006, Arq Bras Endocrinol Metabol, V50, P208, DOI 10.1590/S0004-27302006000200007-
hcfmusp.relation.referenceGlintborg D, 2008, J CLIN ENDOCR METAB, V93, P3618, DOI 10.1210/jc.2008-0760-
hcfmusp.relation.referenceGoodarzi MO, 2005, FERTIL STERIL, V84, P766, DOI 10.1016/j.fertnstert.2005.03.051-
hcfmusp.relation.referenceHIRSHMAN MF, 1990, J BIOL CHEM, V265, P987-
hcfmusp.relation.referenceHojlund K, 2008, DIABETES, V57, P357, DOI 10.2337/db07-0706-
hcfmusp.relation.referenceHorakova O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043764-
hcfmusp.relation.referenceJoost HG, 2002, AM J PHYSIOL-ENDOC M, V282, pE974, DOI 10.1152/ajpendo.00407.2001-
hcfmusp.relation.referenceKarlsson HKR, 2007, CELL BIOCHEM BIOPHYS, V48, P103, DOI 10.1007/s12013-07-0030-9-
hcfmusp.relation.referenceKnochenhauer ES, 1998, J CLIN ENDOCR METAB, V83, P3078, DOI 10.1210/jc.83.9.3078-
hcfmusp.relation.referenceKristiansen S, 1996, AM J PHYSIOL-ENDOC M, V270, pE197-
hcfmusp.relation.referenceLegro RS, 1999, J CLIN ENDOCR METAB, V84, P165, DOI 10.1210/jc.84.1.165-
hcfmusp.relation.referenceLoviscach M, 2000, DIABETOLOGIA, V43, P304, DOI 10.1007/s001250050048-
hcfmusp.relation.referenceMarcondes J. A. M., 2007, ENDOCRINOLOGIA, P635-
hcfmusp.relation.referenceMarcondes JAM, 2007, ARQ BRAS ENDOCRINOL, V51, P972, DOI 10.1590/S0004-27302007000600012-
hcfmusp.relation.referenceMarcondes JAM, 2011, ARQ BRAS ENDOCRINOL, V55, P6, DOI 10.1590/S0004-27302011000100002-
hcfmusp.relation.referenceMiyazaki Y, 2003, DIABETES, V52, P1943, DOI 10.2337/diabetes.52.8.1943-
hcfmusp.relation.referencePanidis D., 2012, CLIN ENDOCRINOLOGY-
hcfmusp.relation.referenceChang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004-
hcfmusp.relation.referenceRocha MP, 2011, GYNECOL ENDOCRINOL, V27, P814, DOI 10.3109/09513590.2010.508852-
hcfmusp.relation.referenceSathyapalan T, 2012, EUR J ENDOCRINOL, V166, P575, DOI 10.1530/EJE-11-0755-
hcfmusp.relation.referenceShaw LJ, 2008, J CLIN ENDOCR METAB, V93, P1276, DOI 10.1210/jc.2007-0425-
hcfmusp.relation.referenceSkov V., 2008, PLOS ONE, V3-
hcfmusp.relation.referenceSkov V, 2007, DIABETES, V56, P2349, DOI 10.2337/db07-0275-
hcfmusp.relation.referenceSolomon CG, 2002, J CLIN ENDOCR METAB, V87, P2013, DOI 10.1210/jc.87.5.2013-
hcfmusp.relation.referenceTfaylio H, 2008, ANN NY ACAD SCI, V1135, P85, DOI 10.1196/annals.1429.024-
hcfmusp.relation.referenceThe Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group, 2004, HUMAN REPROD, V19, P41, DOI 10.1093/HUMREP/DEH098-
hcfmusp.relation.referenceVigil P, 2007, HUM REPROD, V22, P2974, DOI 10.1093/humrep/dem302-
hcfmusp.relation.referenceVigorito C, 2007, J CLIN ENDOCR METAB, V92, P1379, DOI 10.1210/jc.2006-2794-
hcfmusp.relation.referenceVrbikova J, 2005, HUM REPROD, V20, P3328, DOI 10.1093/humrep/dei221-
hcfmusp.relation.referenceWild RA, 2010, J CLIN ENDOCR METAB, V95, P2038, DOI 10.1210/jc.2009-2724-
hcfmusp.relation.referenceZawadzki JK, 1992, POLYCYSTIC OVARY SYN, P377-
dc.description.indexMEDLINE-
hcfmusp.remissive.sponsorshipFAPESP-
hcfmusp.citation.scopus15-
hcfmusp.scopus.lastupdate2022-05-06-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar


Files in This Item:
File Description SizeFormat 
art_YANCE_Metabolic_Disturbance_in_PCOS_Clinical_and_Molecular_Effects_2013.PDFpublishedVersion (English)2.76 MBAdobe PDFThumbnail
View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.